Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This test measures the amount of heptacarboxylporphyrin in your urine and reports it relative to creatinine to account for how concentrated or dilute the sample is. Heptacarboxylporphyrin is one of the porphyrins, the building blocks used to make heme, a vital component of hemoglobin and many enzymes.
When enzymes in the heme pathway are slowed or blocked, certain porphyrins can build up and spill into urine. Heptacarboxylporphyrin is often evaluated as part of a fractionated porphyrin panel to help identify patterns seen in specific porphyrias and some liver or bile duct conditions.
Your clinician may order this test if you have symptoms suggestive of a porphyria or porphyrin excess, such as fragile or blistering skin in sun-exposed areas, darkening of urine, abdominal pain, or nerve-related symptoms. The result can help distinguish between different disorders and can support monitoring over time.
Results are most useful when interpreted with other tests, such as urine delta-aminolevulinic acid and porphobilinogen, plasma or stool porphyrins, and liver tests. Identifying a characteristic porphyrin pattern can guide treatment decisions, help avoid triggers, and keep you safer during illness, surgery, or medication changes.
A higher heptacarboxylporphyrin result suggests increased production or reduced clearance of certain porphyrins. On its own, it does not diagnose a specific porphyria. Your care team will consider your symptoms and the pattern of other porphyrin fractions to decide whether the result fits a porphyria or another condition, such as liver or bile duct disease. Mild, isolated increases can occur with alcohol use, certain medicines, or intercurrent illness.
If your result is unexpected, your clinician may repeat the test with careful sample handling, order additional porphyrin fractionation, check related markers, or consider genetic testing when appropriate. Following results over time can help monitor treatment and recovery.
Kidney function, very dilute or very concentrated urine, pregnancy, and recent illness can make values harder to interpret. If you have questions or new symptoms, discuss them with your clinician so next steps can be tailored to you.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Porphyrins are light sensitive. Urine should be collected in an opaque or foil-wrapped container, kept cool, and delivered promptly to prevent degradation that can lower results.
Hydration affects urine concentration. Reporting relative to creatinine helps, but very dilute or very concentrated samples can still skew interpretation. Follow collection instructions closely.
Some drugs and hormones can raise porphyrin production or trigger attacks, including estrogens, progesterone, barbiturates, certain anti-seizure drugs, rifampin, and some antibiotics. Tell your clinician all medicines you take.
Alcohol use and smoking can increase porphyrin production and worsen liver stress, potentially elevating urinary porphyrins. Reducing or avoiding these exposures can improve results.
Liver disease, iron overload, or bile flow problems can change porphyrin patterns and raise heptacarboxylporphyrin. Your clinician may check liver tests if results are abnormal.
Because the result is normalized to creatinine, impaired kidney function or unusual creatinine excretion can affect the ratio and complicate interpretation.
Hormonal shifts, acute illness, fasting, or stress can alter porphyrin metabolism. Let your clinician know if you are pregnant or recently ill when the sample was collected.
References